High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-09
DOI
10.1038/s41598-017-17704-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ibrutinib inhibits pre-BCR+B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK
- (2016) Ekaterina Kim et al. BLOOD
- Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
- (2016) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC and can be targeted by SYK inhibition
- (2016) S Köhrer et al. LEUKEMIA
- Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
- (2016) Takahiko Yasuda et al. NATURE GENETICS
- Exploring genomic alteration in pediatric cancer using ProteinPaint
- (2016) Xin Zhou et al. NATURE GENETICS
- Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
- (2016) Jinghui Zhang et al. NATURE GENETICS
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
- (2016) Henrik Lilljebjörn et al. Nature Communications
- Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan
- (2016) T Imamura et al. Blood Cancer Journal
- Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
- (2016) Judith M. Boer et al. Oncotarget
- Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
- (2016) Yuan-Fang Liu et al. EBioMedicine
- Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia
- (2015) M. Muschen BLOOD
- Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies
- (2015) Y Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
- (2015) A. Wiestner HAEMATOLOGICA
- Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates
- (2015) J. M. Boer et al. HAEMATOLOGICA
- The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
- (2015) J Eswaran et al. LEUKEMIA
- Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates
- (2015) J. M. Boer et al. HAEMATOLOGICA
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
- (2015) A. Wiestner HAEMATOLOGICA
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
- (2015) Kathryn G. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- A review of a novel, Bruton’s tyrosine kinase inhibitor, ibrutinib
- (2014) Chung-Shien Lee et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL
- (2013) A. van der Veer et al. BLOOD
- An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
- (2013) E Clappier et al. LEUKEMIA
- ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia
- (2013) M Zaliova et al. LEUKEMIA
- A 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia
- (2013) Ching-Hon Pui et al. SEMINARS IN HEMATOLOGY
- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
- (2012) Kathryn G. Roberts et al. CANCER CELL
- Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03
- (2012) Gabriele Escherich et al. PEDIATRIC BLOOD & CANCER
- The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)
- (2011) G. Escherich et al. HAEMATOLOGICA
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
- (2010) R. C. Harvey et al. BLOOD
- Loops Govern SH2 Domain Specificity by Controlling Access to Binding Pockets
- (2010) T. Kaneko et al. Science Signaling
- CGHnormaliter: an iterative strategy to enhance normalization of array CGH data with imbalanced aberrations
- (2009) Bart PP van Houte et al. BMC GENOMICS
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
- (2009) Monique L Den Boer et al. LANCET ONCOLOGY
- Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)
- (2009) Anjo J Veerman et al. LANCET ONCOLOGY
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of STAP-1 promotes neurotoxic activation of microglia
- (2008) Katharina Stoecker et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells
- (2008) Stephen J Loughran et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search